Wong Martin C S, Ching Jessica Y L, Ng Simpson, Lam Thomas Y T, Luk Arthur K C, Wong Sunny H, Ng Siew C, Ng Simon S M, Wu Justin C Y, Chan Francis K L, Sung Joseph J Y
Institute of Digestive Disease, Chinese University of Hong Kong, 7/F, Lui Che Woo Clinical Science Building, Prince of Wales Hospital, Shatin, NT, HKSAR.
School of Public Health and Primary Care, Chinese University of Hong Kong, Shatin, 4/F, School of Public Health Building, Prince of Wales Hospital, Shatin, NT, Hong Kong, HKSAR, China.
Sci Rep. 2016 Feb 3;6:20080. doi: 10.1038/srep20080.
We evaluated the performance of seven existing risk scoring systems in predicting advanced colorectal neoplasia in an asymptomatic Chinese cohort. We prospectively recruited 5,899 Chinese subjects aged 50-70 years in a colonoscopy screening programme(2008-2014). Scoring systems under evaluation included two scoring tools from the US; one each from Spain, Germany, and Poland; the Korean Colorectal Screening(KCS) scores; and the modified Asia Pacific Colorectal Screening(APCS) scores. The c-statistics, sensitivity, specificity, positive predictive values(PPVs), and negative predictive values(NPVs) of these systems were evaluated. The resources required were estimated based on the Number Needed to Screen(NNS) and the Number Needed to Refer for colonoscopy(NNR). Advanced neoplasia was detected in 364 (6.2%) subjects. The German system referred the least proportion of subjects (11.2%) for colonoscopy, whilst the KCS scoring system referred the highest (27.4%). The c-statistics of all systems ranged from 0.56-0.65, with sensitivities ranging from 0.04-0.44 and specificities from 0.74-0.99. The modified APCS scoring system had the highest c-statistics (0.65, 95% C.I. 0.58-0.72). The NNS (12-19) and NNR (5-10) were similar among the scoring systems. The existing scoring systems have variable capability to predict advanced neoplasia among asymptomatic Chinese subjects, and further external validation should be performed.
我们评估了七种现有风险评分系统在预测无症状中国队列中晚期结直肠肿瘤方面的性能。我们在一项结肠镜筛查项目(2008 - 2014年)中前瞻性招募了5899名年龄在50 - 70岁的中国受试者。评估的评分系统包括来自美国的两种评分工具;分别来自西班牙、德国和波兰的各一种;韩国结直肠癌筛查(KCS)评分;以及改良的亚太结直肠癌筛查(APCS)评分。对这些系统的c统计量、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)进行了评估。根据筛查所需人数(NNS)和结肠镜检查转诊所需人数(NNR)估算了所需资源。在364名(6.2%)受试者中检测到晚期肿瘤。德国系统转诊进行结肠镜检查的受试者比例最低(11.2%),而KCS评分系统转诊比例最高(27.4%)。所有系统的c统计量范围为0.56 - 0.65,敏感性范围为0.04 - 0.44,特异性范围为0.74 - 0.99。改良的APCS评分系统具有最高的c统计量(0.65,95%置信区间0.58 - 0.72)。各评分系统之间的NNS(12 - 19)和NNR(5 - 10)相似。现有评分系统在预测无症状中国受试者晚期肿瘤方面的能力各不相同,应进行进一步的外部验证。